Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Abstract Background Preclinical evidence from us and others demonstrates that the anticancer effects of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors can be enhanced with focal radiation therapy (RT), but only when RT is delivered prior to (rather than after) CDK4/6 inhibition. Depending on tumor...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2023-02-01
|
| Colección: | Journal of Translational Medicine |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12967-023-03964-4 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
